Status: current, Defined. Date: 30-Jun 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5074134012 | Product containing precisely chlorzoxazone 500 milligram and diclofenac potassium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
5074135013 | Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
5074136014 | Acetaminophen 325 mg and chlorzoxazone 500 mg and diclofenac potassium 50 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet | Is a | Chlorzoxazone and diclofenac and paracetamol only product in oral dose form | true | Inferred relationship | Some | ||
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Some | ||
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet | Has precise active ingredient | Diclofenac potassium | true | Inferred relationship | Some | 1 | |
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet | Has BoSS | Diclofenac potassium | true | Inferred relationship | Some | 1 | |
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet | Has precise active ingredient | Paracetamol | true | Inferred relationship | Some | 2 | |
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet | Has BoSS | Paracetamol | true | Inferred relationship | Some | 2 | |
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 2 | |
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet | Has precise active ingredient | Chlorzoxazone | true | Inferred relationship | Some | 3 | |
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet | Has BoSS | Chlorzoxazone | true | Inferred relationship | Some | 3 | |
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Chlorzoxazone 500 mg and diclofenac potassium 50 mg and paracetamol 325 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 3 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian dialect reference set